Hollmann K, Mailath G, Rasse M, Kühlböck J, Stadler B
Dept. of Oral and Maxillo-Facial Surgery, University of Vienna, Austria.
J Craniomaxillofac Surg. 1990 Feb;18(2):88-90. doi: 10.1016/s1010-5182(05)80205-7.
At the Department of Oral Maxillo-Facial Surgery, University of Vienna, we have from January 1973 to September 1985, subjected 117 patients with inoperable malignant tumours in the maxillo-facial area to intra-arterial chemotherapy consisting of methotrexate and bleomycin. In this group 103 patients have also been given radiotherapy. In this report only 68 patients of the group of 103 patients who have undergone combined treatment have been considered eligible for evaluation on the basis of their post-therapeutic survival time, which ranged from 2 to 11 years. 10 cases with complete remission and 34 cases with partial remission were observed, indicating that 65% responded to combined treatment.
在维也纳大学口腔颌面外科,从1973年1月至1985年9月,我们对117例颌面部无法手术的恶性肿瘤患者进行了由甲氨蝶呤和博来霉素组成的动脉内化疗。在这组患者中,103例还接受了放射治疗。在本报告中,在103例接受联合治疗的患者中,只有68例患者因其治疗后的生存时间在2至11年之间而被认为符合评估条件。观察到10例完全缓解,34例部分缓解,表明65%的患者对联合治疗有反应。